돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1357023생성일: 2026년 10월 27일

Deoxynojirimycin → Deoxynojirimycin

https://huagongshe.com/reaction/1357023

반응식

참여 물질

역할이름HCID투입량
반응물DeoxynojirimycinHCID 29435—
반응물FagomineHCID 72259—
반응물MigalastatHCID 176077—
생성물DeoxynojirimycinHCID 29435—
생성물(2r,3r,5s,6r)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triolHCID 159496—
생성물HomomannojirimycinHCID 195553—
생성물HCID 178521053HCID 178521053—

반응 단계

1-deoxynojirimycin (DNJ) (1) was isolated from the roots of Morus alba (Moraceae) as described previously (28). 1-Deoxymannojirimycin (manno-DNJ) (2) and 1-deoxy-3,4-diepi-nojirimycin (gulo-DNJ) (5) have been recently isolated from the barks of Angylocalyx pynaertii (Leguminosae). 1-Deoxy-3-epi-nojirimycin (allo-DNJ) (3) was prepared by the microbial redox reaction at C-3 of the N-benzyloxycarbonyl derivative of DNJ as described previously (29) 1-Deoxygalactonojirimycin (DGJ) (4) and 1,2-dideoxy-galactonojirimycin (6) were prepared by the chemical epimerization of the 4-OH group 1 and fagomine, respectively, according to the literature procedure (30). α-Homonojirimycin (α-HNJ) (7), α-homomannojirimycin (α-manno-HNJ) (8), and α-homoallonojirimycin (α-allo-HNJ) (9) were isolated from the whole plant of Aglaonema treubii (Araceae) as reported previously (31). α-Homogalactonojirimycin(α-galacto-HNJ) (10) was prepared from 2,3,4,6-tetra-O-benzyl -D-galactose by way of a Wittig chain extension and a mercuricyclization according to the literature procedure (33). N-Methyl-DGJ (11) was prepared by treatment of 4 with 37% HCHO and 80% formic acid according to the reference (34), and the N-ethyl (12), N-propyl (13), N-butyl (14) and N-hydroxyethyl (15) derivatives of 4 were prepared by treatment with the appropriate alkyl bromide and triethylamine in DMF. The reaction mixture of N-alkylation was evaporated in vacuo, and the residual syrup was resolved in MeOH and applied to an Amberlyst 15 column (H+ form), washed with MeOH, eluted with 0.5 M NH4OH, and concentrated. N-Alkylated derivatives were finally purified by Dowex 1×2 (OH form) and Amberlite CG-50 (NH4+ form) chromatography with as eluent. β-1-C-Butyl-DGJ (16) was isolated from Adenophorae Radix as described previously (35). 4-epi-isofagomine (21), isofagomine (33) and its derivatives (34-37) were chemically synthesized as described previously (40). 2,5-Dideoxy-2,5-imino-D-mannitol (DMDP, 27), 1,4-dideoxy-1,4-imino-D-arabinitol (DAB, 28) were purified from Dermis malaccensis and Morus alba, respectively (29). N-butyl-DNJ (30), N-dodecyl-DNJ (31), castanospermine (29) were from commercial sources. Calystegine A3 (17), calystegine A5 (22), calystegine B1 (23), calystegine B2 (18), calystegine B3 (24), calystegine B4 (25), and calystegine C1 (26) were prepared as published method (36, 40a), N-methyl calystegine A3 (19) and N-methyl calystegine B2 (20) were chemically synthesized. Structural characterization of some inhibitors The structural characterization of the inhibitors is determined by mass spectrometry and 13C-NMR, and some of the results are presented below.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06589964B2
출처 데이터셋uspto-grants-2003_07
ORD IDord-be1082d028424aaea30507463cb447fb
출처 메모uspto-grants-2003_07